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Abstract
Background: The HIV epidemic remains a concern on the global health agenda, despite progress made in
reducing incidence. Investigation of trends among young people is important for monitoring HIV incidence and
informing programming. The study examined geographical and sub-population differences in HIV prevalence
trends among young people aged 15–24 years in Zambia.
Methods: This study analysed data from Zambia Demographic and Health Surveys (ZDHSs) that were conducted in
2001–2, 2007, and 2013–14. A two-stage cluster stratified sampling procedure was used to select samples of 8050,
7969, and 18,052 for the three surveys, respectively. Young people (15–24 years) with known HIV status were
selected for analysis. The outcome variable was HIV status. Log binomial regression analysis of generalised linear
models was used to test for trends.
Results: Overall HIV prevalence declined over the period 2001–2 to 2013–14 among women and men aged 15–49
years (17.8 and 12.9% to 15.1 and 11.3%, respectively). There was, however, an increase in HIV prevalence among
urban young men over this period, from 3.7% in 2001–2 to 7.3% in 2013–14 (aRR 2.17, 95% CI 0.99˗4.75), and, in
rural areas, from 2.6 to 3.6% (aRR 1.46, 95% CI 0.78˗2.75). In contrast, HIV prevalence among women declined over
the same period of time. In urban areas, HIV prevalence among women declined from 15.2 to 10.7% (aRR 0.66, 95%
CI 0.53˗0.93), while in rural areas it declined from 8.2 to 4.8% (aRR 0.41, 95% CI 0.59˗0.85). In addition, there was a
narrowing gender gap in terms of HIV infection, as the prevalence ratio of females to males declined from 4.2 and
3.1 to 1.5 and 1.3, in urban and rural areas, respectively.
Conclusions: The increase in HIV prevalence among urban young men over the past 12 years, contrasting
declining trends among young women in both urban and rural populations, suggests differential effects of
prevention efforts. Furthermore, findings that Zambia’s overall national HIV prevalence decline masks some striking
sex and rural/urban differentials, indicate the need for reconsidering the prevention efforts for young urban men.
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Background
The HIV epidemic remains a major concern on the glo-
bal health agenda, despite the progress made in reducing
incidence and improving access to antiretroviral treat-
ment. The focus of the post-2015 era has been nothing
less than the end of the AIDS epidemic by 2030 through
the implementation of an ambitious Joint United Na-
tions Programme on HIV/AIDS (UNAIDS) 90–90-90
treatment target [1]. UNAIDS currently estimates that
36.7 million people are living with HIV infection. In
sub-Saharan Africa, Eastern and Southern Africa are the
hardest hit, with more than half of people living with
HIV residing in this region, despite the fact that only
6.2% of the world’s population resides in this region [2].
The HIV incidence in sub-Saharan Africa peaked during
the mid-1990s and substantially declined during the sub-
sequent 10–15 years [3]. However, since 2010, this con-
sistent declining pattern among adults seems to have
halted, with only marginal overall declines apparent in
Eastern and Southern Africa and with some countries
experiencing an increase in incidence [3, 4].
Monitoring HIV prevalence, patterns, and trends is
important for efficient planning, resource allocation, and
informing programmes. At the global level, antenatal
clinic (ANC)-based surveillance has formed the basis for
the measurement of prevalence (both at local and na-
tional levels), and prevalence change among young
women, which has been used as a proxy for change in
incidence. Estimates of trends in incidence and mortality
are mathematically modelled from ANC and other avail-
able data by the UNAIDS expert group. The UNAIDS/
WHO Spectrum AIDS Impact Model is the most com-
monly used method for deriving HIV incidence [5, 6].
However, ANC data has some inherent biases, including
the exclusion of men, non-pregnant women, and sexu-
ally inactive persons. Therefore, population-based sur-
veys that provide HIV prevalence data have become
increasingly important. Nationally representative house-
hold surveys that are repeated periodically are used to
monitor prevalence and estimate incidence in age-specific
population groups. Specifically, prevalence trends among
young people at subnational levels are an indicator of inci-
dence within the general population [7]. In recent years,
countries in sub-Saharan Africa have included HIV inci-
dence assays and testing algorithms in population based
surveys to measure HIV incidence and monitor HIV im-
pact in accordance with the UNAIDS/WHO recommen-
dation [8]. Zambia implemented the population-based
HIV impact assessment survey (ZAMPHIA) in 2016, the
first survey to measure national incidence [9].
Zambia is one of 15 countries in the world that have
the highest HIV disease burden. It is the leading cause
of death among adults aged 15 years and older in
Zambia with estimates of about 20% of adult deaths
attributed to HIV [10]. An estimated 6.6% of young
people are HIV positive and prevalence is higher among
young women (8%) than men (5%). Annual HIV inci-
dence among persons 15–24 years is 57 new infections
per 10,000 uninfected persons per year.
Monitoring HIV prevalence and associated risk factors
in Zambia is based on a comprehensive ANC-based
surveillance system, population-based surveys in selected
communities, and nationally representative
population-based surveys. ANC-based data covering the
period of 1994–2011 showed declining overall preva-
lence trends among young women; however, these trend
patterns differed significantly according to place and
educational attainment [11–13]. Similarly, a series of
cross-sectional population-based surveys conducted in
select communities in 1995, 1999, and 2003 showed
marked declines in prevalence both among urban and
rural men and women, with declines being associated
with changes in behaviour and strongly skewed towards
the higher educated [14–16]. Furthermore,
population-based survey systems have been used to
validate the representativeness of ANC-based data at
various levels. Similar prevalence estimates were found
at national level using ZDHS 2001–2 as a comparison
[17], and at local level, using data from selected
communities [11]. With respect to trends in prevalence
among young people, the ANC-based data somewhat
underestimated the declines in comparison with the
population-based surveys that were conducted in the
same local settings [18].
HIV prevalence among young people (15–24 years) in
repeated cross-sectional surveys can be used as a good
proxy to monitor changes in incidence over time be-
cause the prevalence in this age group is only marginally
affected by mortality or treatment [19, 20]. They are also
at a stage when sexual and reproductive activity, includ-
ing risky sexual behaviour, usually begins. With the high
burden of HIV infection in Zambia, more detailed ana-
lyses of changes in prevalence among young people in
rural/urban sub-populations and by sex than what is
provided in the published DHS reports, can provide use-
ful information for evaluating epidemic control efforts.
This article examines geographic and sub-population dif-
ferences in HIV prevalence trends among young people
from three rounds of the Zambia Demographic and
Health Surveys (2001–2, 2007, and 2013–14).
Methods
Settings
Zambia is located in Southern Africa with a total land
area of 752,612 sq. km. The current population is esti-
mated at 13 million people with an annual growth rate
of 2.8. More than a third (39%) of the population live in
urban areas. About two-thirds of the population is below
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the age of 25 years with 22% being between 15 and 24
years [21]. The estimated HIV prevalence among those
aged 15–49 years is 13.3 and 6.6% among young people
aged 15–24 years [22].
Data collection
The Zambia Demographic and Health Survey (ZDHS) is a
cross-sectional nationally representative population-based
survey, which has included an HIV testing module since
2001–2. A two-stage stratified cluster sampling procedure
was followed in each of the ZDHS rounds, based on the
2000 population census frame for the 2001–2 and 2007
ZDHS and the 2010 population census frame for the
2013/14 ZDHS. Stratification was achieved by separating
each province into rural and urban areas. Therefore, the
nine provinces gave 18 sampling strata in 2001–2 and
2007, and in 2013–14, when a new province was parti-
tioned, there were 20 sampling strata (strata are non-over-
lapping subgroups from which households or populations
are sampled). The samples for the 2001–2 and 2007
ZDHS were designed to provide estimates of population
and health indicators at the national and provincial levels.
The 2013–14 ZDHS sample was designed to provide esti-
mates at the national level, provincial level, and rural and
urban areas within provinces. At the first stage, primary
sampling units or clusters (EAs) were selected from the
strata with probability proportional to size. An Enumer-
ation Area (EA) is a convenient geographic area with an
average size of 90 and 130 households in rural and urban
areas, respectively. All households in selected clusters
were listed for the three rounds of ZDHS, and an equal
probability systematic sampling of households was done
to obtain target sample sizes of 8050, 7969, and 18,052
households, respectively. All women 15–49 years and men
15–59 years were eligible to participate in the surveys, ex-
cept in the 2001–2 survey where men were only eligible in
one-third of the selected households. Eligible women and
men living in the households selected for the survey were
asked to consent to the syphilis and HIV testing. Young
people (aged 15–24 years) accounted for 44% (or 4280) of
the sample in 2001–2 and 41% (or 5426 and 12,303) in
the two subsequent surveys. In total, 1615, 4235, and
11,571 young people aged 15–24 years with known HIV
status (i.e. those who were successfully interviewed and
consented to providing a Dried Blood Spot (DBS) or ven-
ous blood draw for the HIV testing) were selected for ana-
lysis by the three surveys, respectively. The detailed
methods of the three surveys are reported in the main
Zambia Demographic and Health Survey reports [22–24].
In the ZDHS 2001–2, HIV testing was anonymous and
unlinked to socio-demographic variables apart from sex,
age, urban-rural residence, and province. Venous blood
specimens were collected from consenting participants
and dried blood spot (DBS) samples were prepared on
filter paper for testing. The DBS samples were screened
for HIV antibodies using Wellcozyme HIV 1 & 2 GACE-
LISA. All positive samples and 10% of the negative sam-
ples were retested using BIONOR HIV 1 & 2 and
discordant specimens were tested with Western Blot. In
the 2007 and 2013–14 surveys, blood specimens in the
form of Dried Blood pots (DBS) were collected using fin-
ger pricking. The protocols for HIV testing for these two
surveys allowed for anonymous linking of the HIV results
to the socio-demographic data of individuals interviewed.
Vironostika HIV Antigen /Antibody Combination Assay
(Biomerieux) was used for HIV antibody screening and all
positive samples were retested using ELISA Enzygnost
HIV Integral II Assay (Dade Behring) for confirmatory
testing. For discordant results, specimens were retested
using the two tests. If specimens were still discrepant,
Western Blot was used as a third confirmatory test. Fur-
ther details about the testing methodology can be found
in the ZDHS reports [22–24].
Ethics
The Ethical Review Committee at the University of
Zambia and the Institutional Review Board of ORC
Macro approved the 2001–2 ZDHS. The two subsequent
surveys obtained ethical approval from the Tropical Dis-
ease and Research Centre (TDRC) ethical committee,
the Institutional Review Board of Macro International
and the Centres for Disease Control and Prevention
(CDC) Atlanta research ethics review board. Participa-
tion in the surveys was based on informed and voluntary
consent, and separate consent was sought for HIV and
syphilis testing. Participants were informed that the sur-
vey HIV testing was anonymous. However, a rapid test
was offered to participants in the 2013–14 round by
nurse and lay counsellors who provided homebased
counselling and testing following the national HIV test-
ing algorithm to ascertain HIV infection status for re-
spondents who consented to it. Concurrent HIV testing
with Determine™ HIV ½ and Uni-Gold™ was the field
testing procedure. For samples reactive (positive) to ei-
ther rapid test, further consent was sought to conduct a
venous blood draw for CD4 count testing, using the
PIMA Point of Care CD4 machine. CD4 count results
were returned to participants within 24 h. Participants
were informed about these procedures in accordance
with ethical requirements.
Statistical analysis
Analysis included all survey participants but with a focus
on young people aged 15–24 years. Stratifications was done
by sex and urban/rural residence. The data is restricted to
three data point periods of the population-based surveys.
Data were analysed using STATA version 14.2, and all ana-
lyses were weighted to adjust for complex study design.
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The sample weights also accounted for differences in the
non-response by geographic region and sex. Log-binomial
regression analysis of the generalised linear model was used
to test for trends by determining the statistical significance
of the change in prevalence in the period 2001–2 to 2013–
14. The analysis also controlled for the potential con-
founder age, which was adjusted for as a linear effect.
Results
Participation
The overall participation rates for the three surveys were
similar. In all three surveys, 98% of the households were
successfully interviewed. Participation rates were higher
among women than men (96, 97, and 91% compared to
91, 91, and 89%, respectively). Details of participation in
the 2001/2, 2007, and 2013/14 ZDHS are published in
the detailed reports [22–24].
Participation in the HIV testing was closely similar in
the first two surveys in 2001–2 and 2007 (72–73% for
men and 77–79% for women) and about 10% higher in
the last survey (Table 1). Participation was similar for
rural men and women but substantially higher among
urban women than men. Overall response rates were
lower among men and participants residing in urban
areas (Table 1). Details of HIV participation in the
2001–2, 2007, and 2013–14 ZDHS are published in the
detailed reports [22–24].
Trends overall
Overall HIV prevalence declined over the period 2001/2
to 2013/14 among women and men aged 15–49 years
(17.8 and 12.9% to 15.1 and 11.3%, respectively). A
similar decline was observed in both urban and rural
areas (23.1 and 10.8% to 18.2 and 9.1%, respectively) for
men and women combined. The decline was steeper
among women in urban areas (26.3 to 21.1%) compared
to males (8.9 to 8.1%), data not shown. The age-specific
patterns of change in HIV prevalence over time among
men and women show striking differences, particularly
in the urban areas (Figs. 1 and 2). Whereas HIV in-
creased in the youngest two 5-year age groups among
young men in urban areas, the prevalence declined sub-
stantially in the next three 5-year age groups (25–39
years) and was rather stable among those 40 or older
(Fig. 1a). Among rural men, this pattern of change over
time was less prominent or partly unstable with the ex-
ception of a tendency of declines among those aged 35–
49 years (Fig. 1b). Among women, the age-specific
prevalence estimates declined in all age groups with the
exception of an observed increase in HIV prevalence
among those aged 40–49 both in urban and rural areas
(Fig. 2).
Trends among young people
A higher proportion of young women was HIV-infected
than young men in the three survey rounds. The sex dif-
ferentials by rural/urban residence persisted with a
higher proportion of young women than young men in-
fected in urban than rural areas (Table 2). HIV preva-
lence declined in a linear pattern between 2001–2 and
2013–14 among young women from 15.2 to 10.7% (aRR
0.66, 95% CI: 0.53–0.93) and 8.2 to 4.8% (aRR 0.59, 95%
CI 0.41–0.85), in urban and rural areas, respectively.
Conversely, there was a linear increase in HIV




Women Men Women Men Women Men
No. % Tested No. % Tested No. % Tested No. % Tested No. % Tested No. % Tested
Age group
15–19 629 81.1 459 75.2 1665 76.0 1533 72.5 3840 90.8 3617 85.8
20–24 570 80.3 346 83.4 1476 74.9 1170 70.8 3175 91.0 2532 84.8
25–29 455 80.9 361 79.0 1414 78.1 1104 69.5 2891 90.9 2127 84.0
30–34 334 81.5 281 80.5 1071 78.5 1042 72.0 2514 90.4 2091 82.3
35–39 250 84.5 241 87.3 756 78.0 818 72.7 2054 89.5 1858 82.5
40–44 202 81.3 174 80.6 551 78.8 512 76.4 1527 89.6 1534 82.4
45–49 164 78.8 113 76.9 475 79.2 427 73.3 1062 89.5 1101 81.5
50–54 na na 100 86.8 na na 319 74.0 na na 1349 83.3
55–59 na na 71 74.2 na na 221 76.5 na na
Residence
Rural 1816 79.3 1604 76.8 4088 77.7 3921 75.8 8852 91.7 8549 87.3
Urban 873 79.5 814 66.5 3320 76.4 3225 67.8 8212 89.1 7660 79.8
Overall Response 79.4 73.3 77.1 72.2 90.4 83.7
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prevalence among young men in both urban and rural
populations (3.7 to 7.3% (aRR 2.17, 95% CI: 0.99–4.75)
and 2.6 to 3.6% (aRR 1.46, 95% CI 0.78–2.75)), but only
the trend among urban men was of statistical signifi-
cance (Table 2). Among the young people aged 15–19
and 20–24, there was a narrowing gender gap in terms
of HIV infection. In 2001–2, the women/men prevalence
ratio (15–24 years) was 4.2 and 3.1 in urban and rural
areas, respectively. This ratio reduced to 2.0 and 2.1 in
urban and rural areas, respectively in 2007, and nar-
rowed further to 1.5 and 1.3 in 2013/14.
The data show geographic variation in prevalence trends
(Table 2). Significant declines were observed for young
women resident in urban Lusaka and rural Eastern prov-
ince, while there was a non-significant increase in preva-
lence among young women residing in urban Luapula,
North-Western, and Western. Among young men, a
strong linear increase was observed in urban Copperbelt,
Northern, and Southern provinces. For rural areas, a simi-
lar pattern was observed for Central, Copperbelt, and
Northern provinces.
Discussion
HIV prevalence declined among young women aged 15–
24 years in the past 12 years in both urban and rural
populations, contrasting an increasing trend among
young men in urban areas. This contrast by sex differs
from previous repeated population-based surveys con-
ducted in the 1990s and early 2000s showing declining
trends regardless of sex [14–16]. As a result of the ob-
served trend, the gender disparity in HIV infection nar-
rowed sharply, with the ratio of four and three young
women infected for every young man, in urban and rural
areas, respectively, in 2001/2 and then being reduced to
1.5 and 1.3 in 2013/14. HIV prevalence among young
people has been found to be a good proxy indicator of
new infections, and our findings seem not to support
the reported UNAIDS estimates of HIV incidence de-
clines in Zambia since 2001 [25].
There was a relative increase in HIV prevalence from
2001/2 to 2013/14 of 38.5 and 97.3% among young men
residing in rural and urban areas, respectively, while
among young women the corresponding relative de-
clines in rural and urban areas were 41.5 and 29.6%.
Mahy et al. (2012), in a study investigating trends in
HIV prevalence among young people in generalised epi-
demics in selected sub- Saharan African countries, in-
cluding Zambia, between 2000 and 2011, observed that
while overall results showed declines in HIV prevalence,
further investigations showed differences in trends in
prevalence among men and women. Eight of 14 countries
had significant declines among young people when
A B
Fig. 1 a-b HIV prevalence by age and rural/urban among young men 15–24 years, 2001–2, 2007, and 2013–14 ZDHS
A B
Fig. 2 a-b HIV prevalence by age and rural/urban among young women 15–24 years, 2001–2, 2007, and 2013–14 ZDHS
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women and men were combined. However, nine countries
observed significant declines restricted to women only
and only two countries revealed significant declines
among young men (Cameroon and Tanzania). Estimates
from three countries suggested increasing trends for men
aged 15–24 [19].
The age-specific pattern of change in HIV prevalence
over time among those aged 25 years and older differed
somewhat by gender. Prevalence declined substantially
in the age groups 25–39 years and was rather stable
among those 40 years and/or older among urban men.
Among rural men, this pattern of change was less prom-
inent or partly unstable with the exception of a tendency
of declines among those aged 35–49 years. The pattern
among urban and rural women was closely similar and
HIV prevalence tended to increase among those aged
40 years and older. We expected to see a pattern of in-
crease in prevalence in older age groups as a result of
the substantial improvement in treatment coverage the
past five to 10 years. This gender differential could partly
Table 2 HIV prevalence and age-adjusted risk ratios estimates for ZDHS (2001–2, 2007, and 2013–14) by rural/urban residence,
province, and age group among young people (aged 15–24 years)
Women Men
2001/2 2007 2013/14 2001/2–2013/14 P-value 2001/2 2007 2013/14 2001/2–2013/14 P-value
% % % aOR (CI) % % % aOR (CI)
Urban 15.2 11.2 10.7 0.66 (0.53–0.93)** 0.02 3.7 5.7 7.3 2.17 (0.99–4.75)** 0.05
Age Group
15–19 9.0 5.5 6.6 0.73 (0.41–1.30) 0.29 2.4 4.3 5.9 2.52 (0.60–10.62) 0.21
20–24 22.7 18.8 15.4 0.63 (0.41–0.96)** 0.03 4.9 7.6 9.1 1.87 (0.77–5.04) 0.16
Province
Central 15.9 15.3 9.8 0.50(0.17–1.39) 0.18 4.3 10.4 3.9 0.88 (0.10–7.54) 0.91
Copperbelt 12.3 8.9 10.6 0.82(0.43–1.56) 0.55 2.8 5.2 10.7 4.34 (1.03–18.32)** 0.05
Eastern 0.0 11.1 11.0 0.0 2.9 4.9 –
Luapula 11.1 10.5 18.3 1.87(0.25–13.81) 0.54 0.0 1.6 9.5 –
Lusaka 20.8 10.8 9.0 0.38(0.21–0.69)*** 0.00 6.0 7.3 4.3 0.75 (0.21–2.66) 0.66
Muchinga – – 6.5 – – – 6.4 –
Northern 11.8 8.8 9.4 0.62(0.12–3.10) 0.56 0.0 1.0 6.8 –
N/Western 5.9 9.4 7.9 1.37(0.18–11.25) 0.77 6.8 0.0 5.3 0.99 (0.14–7.21) 0.99
Southern 21.7 19.7 17.6 0.79(0.27 - 2.30) 0.67 0.0 5.2 8.9 –
Western 18.2 21.1 19.2 1.36(0.31–6.08) 0.68 16.7 9.4 11.8 0.52 (0.06–4.85) 0.56
Rural 8.2 6.2 4.8 0.59(0.41–0.85)*** 0.01 2.6 2.9 3.6 1.46 (0.78–2.75) 0.24
Age Group
15–19 4.7 5.9 3.2 0.68 (0.38–1.23) 0.20 1.6 3.0 2.5 1.64 (0.69–3.89) 0.26
20–14 11.9 6.5 6.9 0.57(0.36–0.89)*** 0.01 4.0 2.9 5.3 1.40 (0.59–3.33) 0.45
Province
Central 7.5 14.8 8.1 1.03(0.44–2.38) 0.95 3.4 3.0 6.0 1.87 (0.49–7.11) 0.36
Copperbelt 11.1 4.1 5.6 0.48(0.13–1.81) 0.28 0.0 2.0 10 –
Eastern 10.4 2.9 3.3 0.37(0.14–0.94)** 0.04 4.2 2.1 2 0.53(0.12–2.44) 0.42
Luapula 6.4 8.2 5.6 0.90(0.28–2.85) 0.85 0.0 12 3.7 –
Lusaka 5.0 8.3 4.0 0.70(0.09–5.55) 0.73 0.0 2.1 1.7 –
Muchinga – – 2.0 – – – 2.4 –
Northern 5.4 3.9 4.5 0.84(0.31–2.28) 0.73 1.1 2.4 6.3 5.96(0.77–46.22) 0.09
N/Western 6.5 3.1 3.7 0.56(0.19–1.64) 0.29 6.6 0.0 2.7 0.39(0.12–1.31) 0.13
Southern 6.9 6.5 4.9 0.68(0.23–2.02) 0.49 3.8 2.6 1.7 0.47(0.08–2.61) 0.39
Western 12.7 8.4 6.1 0.48(0.19–1.21) 0.12 2.4 1.1 3.6 2.02(0.18–22.31) 0.57
The dash (−) represents missing cases
% percentage, aOR age – adjusted Odds Ratio and CI Confidence Interval
Significant results are in bold (p < 0.05)
P-values are from the log-binomial regression analysis test for trends. Figures with asterix are significat at *(p < 0.10) **(P < 0.05) ***(P < 0.01)
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be due to the fact that women are likely to access treat-
ment at an earlier stage of infection as compared to
men. Through the Prevention of Mother to Child Trans-
mission (PMTCT) programme, women have had higher
access to Antiretroviral Therapy (ART) than men.
Health-seeking behaviour is generally also better among
women than men, leading to early initiation of ART [26,
27]. Comparisons of HIV prevalence trends by the two
age groups (15–19 vs. 20–24) might be difficult to judge
due to small numbers.
The first population-based HIV survey conducted in
Zambia revealed the HIV prevalence to be 6.9 times
higher in women compared to men aged 15–24 years in
urban areas [28]. This sharp contrast in transmission has
been observed for a long time and found consistently in
countries with generalised epidemics [29]. Idele et al.
(2014) reported that in Swaziland the HIV prevalence
among adolescent girls was five times higher than
among adolescent boys and this gap persisted into young
adulthood. Similarly in countries such as Botswana,
South Africa, and Uganda, the sex disparity is evident
among adolescent and young adults [30]. Our observa-
tion showing the prevalence ratio in Zambia ap-
proaching one raises an urgent research question: What
could be the major explanation for this sudden change
in the gender difference in HIV prevalence? The differ-
ences in the direction of HIV prevalence trends among
young women and men may reflect differences in inten-
sity and focus of prevention programmes. In the 1990s,
Zambia like many other African countries implemented a
multi-sectoral national response with emphasis on an in-
tensive prevention strategy. With the access-to-treatment
campaign, much of the preventive focus was gradually
weakened or shifted [31]. Women have been prioritised as
a target group in prevention programmes, particularly
young women, most likely due to the observed sex dispar-
ity in HIV infection among young women and men [32].
This was strengthened further with the very successful
building up of the prevention of mother-to-child transmis-
sion programmes in the past 10 years. Important examples
of more recent shifts in prevention policies that might
have played a role in explaining gender differentials in
transmission trends are the promotion of Voluntary Med-
ical Male Circumcision (VMMC) and the HIV Treatment
as Prevention strategy (TasP). TasP raised optimism fol-
lowing studies showing the biological plausibility of anti-
retroviral therapy to reduce HIV transmission through
viral suppression [33]. It is plausible that this may have in-
fluenced changes in perceived risk of HIV among young
men and consequently their behaviour. Kalichman et al.
(2010), in a study investigating the association between
sexually transmitted infections and infectiousness beliefs,
found that there was an association between believing one
is less infectious when viral load is undetectable and being
diagnosed with an STI [34]. This finding seems to confirm
that infectiousness beliefs play a role in continued HIV
transmission risk. Crepaz et al. (2004), in a meta-analytical
review, also found that people’s beliefs about HAART and
viral load may promote unprotected sex [35].
The participation differentials across survey rounds
could have biased the underlying population prevalence
estimates. In the two first rounds, the non-participation
was about 25% and then reduced to 15% in the most
recent round. Observed non-participation was higher
among men and mobility may have played a major role.
With observed associations between mobility and vul-
nerability to infection, surveys with substantial non-par-
ticipation may somewhat underestimate the HIV
prevalence among men. However, a study that analysed
five population-based surveys found that non-response
did not bias national estimates from population-based
studies significantly, especially in countries with rela-
tively high prevalence [36, 37]. Barnighausen, using
Heckman-type selection models to test and correct for
unobserved factors, found evidence of a downward
selection bias in existing national HIV prevalence esti-
mates for men in 2007 in Zambia. Based on the assump-
tion that non-participation may be correlated with
unobserved personal characteristics, they used a bivari-
ate probit selection model to estimate whether being
available for, and consenting to testing is correlated with
HIV status [36]. Conversely, the 2013–14 provision of
home-based testing seemed to have had a positive im-
pact on participation, with substantially more individuals
willing to know their status and consent to HIV testing.
We can therefore assume reduced refusal rates among
HIV-positive individuals. This might, to some extent,
have affected the estimated trend, i.e. assuming reduced
underestimation in the final survey round implies that
the real prevalence may have declined somewhat more
among women than the estimates indicate, and corres-
pondingly that the real increase among young men may
be somewhat smaller than what the estimates suggest.
The magnitude of these effects is likely to be marginal
since the level of improved participation was rather
modest.
Conclusion
In conclusion, the findings of an increase in HIV preva-
lence among young urban men in the past 12 years,
contrasting declining trends among young women in
both urban and rural populations, suggests differential
effects of prevention efforts. Further, the overall na-
tional HIV prevalence decline has thus concealed some
striking sex and rural-urban differentials both for
trends over time and prevalence levels. This has poten-
tial to mislead policies and highlights the need for
reconsidering targeted prevention efforts. The evidence
Nakazwe et al. BMC Infectious Diseases          (2019) 19:432 Page 7 of 9
in this study suggests that national sub-epidemics must
be assessed and considered in a concerted effort to re-
duce HIV infections.
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